Michael J. Fox Foundation and Prothena Seek Novel Biomarkers for Parkinson’s Disease
The Michael J. Fox Foundation for Parkinson’s Research and Prothena Corporation announced a collaboration to find new biomarkers for Parkinson’s disease (PD) progression. They will focus on molecules related to alpha-synuclein, a protein found in the brain of people with PD that may contribute to the cause of the disease. A biomarker…